Skip to Main Content

Paper Details

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.
Mol Cancer Ther
2
2022
CDK4/6, E2F target genes, G3MB, G3MBs, Gemcitabine, MB, Medulloblastoma, RB, Ribociclib, Tumors, children, gemcitabine, genes, human, luciferase, luciferase-labeled mouse and human G3MBs, medulloblastoma, mice, mouse, patient, ribociclib, tumor, tumors
Author NameAffiliation
Paul A NorthcottSt. Jude Children's Research Hospital
Paul A NorthcottSt. Jude Children's Research Hospital
Giles W RobinsonSt. Jude Children's Research Hospital
Giles W RobinsonSt. Jude Children's Research Hospital
Martine F RousselSt. Jude Children's Research Hospital
  • 1 - 5

Datasets

Release 1.2